Department of Experimental and Clinical Pharmacology
The Experimental and Clinical Pharmacology graduate program at the University of Minnesota College of Pharmacy is an innovative, interdisciplinary program that trains students to conduct research encompassing methodology from basic and clinical pharmacology perspectives. In our program, students study:
Graduates are prepared for distinguished careers in clinical research
- Experimental Pharmacotherapy
- Drug metabolism
- Infectious disease
Dr. Elizabeth Hirsch joined ECP in July 2017. In her first year with our faculty, she has had a significant impact on research, teaching, and service in the department.
Dr. Hirsch has two sponsored studies ongoing: "Activity of Ceftolozane/Tazobactam (C/T) and Ceftazidime/Avibactam (CZA) against Multidrug-Resistant Clinical Isolates" and "A Retrospective Multi-Center Study to Assess Patient Outcomes Following Treatment with Ceftolozane/Tazobactam," along with multiple other projects.
Dr. Hirsch mentors undergraduate UROP awardee Jadyn Anderson and research-emphasis PD3 students Melanie Mahoney and Elizabeth Smith.
Elizabeth was recently awarded a summer Melendy scholarship for her project, "Characterizing the Activity of Fosfomycin against Pseudomonas aeruginosa and Identifying Contemporary Bacterial Resistance Mechanisms".
Advancing the science of human pharmacology and therapeutics through translational research
Research conducted by department faculty can focus on a range of topics, diseases/conditions, and investigational methods. Some current and recent projects are highlighted here:
- Alzheimer's Disease
- Community Health
- Drug Dependence
- Pharmacometrics/ Pharmacokinetic modeling
- Seizure Disorders
- Infectious Disease
Professor Robert Straka is a recipient of this year's University of Minnesota President's Community-Engaged Scholar Award - Collegiate. The award recognizes exemplary community-engaged scholarship by a faculty member whose academic career has reflected longstanding commitment to the University's definition of public engagement.
Ling Li has been selected as the recipient of the 2015-2016 Fesler-Lampert Chair in Aging Studies by the Center on Aging.
This cross-disciplinary paradigm translates basic scientific discoveries into safe and effective therapeutic uses by providers and patients, through laboratory experiments and clinical studies. Clinical data can also prompt new questions and investigations, leading back to the bench and beginning a new cycle of translational research.